Skip to main content
Log in

Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Derivatives of dihydro-digitoxin (DHD) were studied in the search for a glycoside with a primarily extra-renal clearance and a faster elimination rate than digitoxin. The positive inotropic doses of the derivatives of DHD were higher than those of digitoxin and digoxin. There was no significant difference in the therapeutic margin. After injection of 3H-digoxin in unaesthetized cats, no metabolites were found in the serum which did not bind with the antibody used for the RIA. After injection of 3H-digitoxin, and its derivatives, the radioactivity was cleared from the serum at a much lower rate than the concentrations assayed by RIA. The metabolites which did not bind to the digitoxin antibody were hydrophilic and had a low protein binding. Digitoxin-bisdigitoxoside (Dt-2) determined by RIA rapidly disappeared from the serum. The radioactivity remaining after 24 h was eliminated with a half-life of 219 h. Ten min after injection of DHD the serum contained no unchanged DHD, but 36% digitoxin suggesting that the reduction of digitoxin to DHD is reversible and that the conversion of DHD to Dt-2 is the rate limiting step in the metabolism of digitoxin. The total body clearance of digitoxin, its metabolites and derivatives determined by RIA increased in the order DHD-oxime ⩽ digitoxin > DHD ⩽ DHD-acetyloxime < DHD-methyloxime. The clearance and the elimination rate of DHD-methyloxime were significantly higher than those of digitoxin (P = 0.05).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Betzien G, Dietmann K, Schaumann W (1980) Resorption, renale und extrarenale Clearance von Digoxin. Herz/Kreisl 12:115–120

    Google Scholar 

  • Bolton GR, Powell W (1982) Plasma kinetics of digoxin in the cat. Am J Vet Res 43:1994–1999

    Google Scholar 

  • Flasch H, Heinz N, Petersen R (1977) Affinität von polaren Digoxin- und Digitoxin-Metaboliten zu Digoxin- und Digitoxin-Antikörpern. Arzneimittelforsch 27:649–653

    Google Scholar 

  • Graves PE, Fenster PE, MacFarland RT, Marcus FI, Perrier D (1984) Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in normal subjects. Clin Pharmacol Ther 36:601–606

    Google Scholar 

  • Haberland G, Maerten G (1969) Spezifischer Deuterium- und Tritium-Austausch in Cardenoliden und Cardenolidglykosiden. Naturwissenschaften 56:516

    Google Scholar 

  • Hempelmann FW, Heinz N (1978) Lipophilie und Proteinbindung bei Cardenoliden. Arzneimittelforsch 28:2185–2187

    Google Scholar 

  • Kroneberg G, Schaumann W, Stoepel K (1962) Wirkungsdauer und enterale Resorption von Digitoxigenin-monodigitoxosid (Dt 21). Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 201:91–98

    Google Scholar 

  • Perrier D, Mayersohn M, Marcus FI (1977) Clinical pharmacokinetics of digitoxin. Clin Pharmacol 2:292–311

    Google Scholar 

  • Petersen R, Flasch H, Heinz N (1977) Darstellung und Eigenschaften einiger Glukuronide und Sulfate von Cardenoliden und Cardenolid-glykosiden. Arzneimittelforsch 27:642–649

    Google Scholar 

  • Repke K (1959) Die Bis- und Mono-digitoxoside des Digitoxigenins und Digoxigenins: Metaboliten des Digitoxins. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 237:155–170

    Google Scholar 

  • Repke K, Herrmann I (1962) Speziesunterschiede in der Geschwindigkeit der fermentativen Inaktivierung von Digitoxin. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 243:331–333

    Google Scholar 

  • Schaumann W, Kaufmann B (1982) Explanation of the biologically implausible correlation between distribution volume and total body clearance in an open two-compartment model. Int J Clin Pharmacol Ther Toxicol 20:508–510

    Google Scholar 

  • Schmoldt A, Herzberg W, Van Ackeren H, Benthe HF (1983) On the cleavage of digitoxin (Dt-3) by human liver microsomes. Naunyn-Schmiedeberg's Arch Pharmacol 322:R 110

    Google Scholar 

  • Schmoldt A, Rohloff C (1978) Dehydro-digitoxosides of digitoxigenin: formation and importance for the digitoxin metabolism in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 305:167–172

    Google Scholar 

  • v. Wartburg A, Kalberger F, Rutschmann J (1965) Tritium-labelled cardiac glycosides: digoxin (12 Alpha-3H). Biochem Pharmacol 14:1883–1889

    Google Scholar 

  • Weidler DJ, Jallad NS, Movahhed HS, Sakmar E, Wagner JG (1978) Pharmacokinetics of digoxin in the cat and comparisons with man and the dog. Res Commun Chem Pathol Pharmacol 19:57–66

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Send offprint requests to W. Schaumann at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauer, I., Neubert, P. & Schaumann, W. Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats. Naunyn-Schmiedeberg's Arch Pharmacol 335, 469–475 (1987). https://doi.org/10.1007/BF00165565

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165565

Key words

Navigation